Recombinant DNA human interferon alpha 2 in advanced breast cancer: a phase 2 trial.

Effectiveness of recombinant DNA (rDNA) human interferon alpha 2 (IFN alpha 2) in advanced breast cancer was evaluated in 14 patients who had received prior endocrine and/or cytotoxic therapy. After randomization, 7 patients received IFN alpha 2 two million IU m-2 day-1, s.c., 3 times a week (schedu...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmanabhan, N., Balkwill, F. R., Bodmer, J. G., Rubens, R. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1985
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976812/
https://www.ncbi.nlm.nih.gov/pubmed/3917678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976812/
https://www.ncbi.nlm.nih.gov/pubmed/3917678

Ejemplares similares